Articles
10
All (10)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (6)
Scopus (6)
Other Publications (4)
2. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic
International Journal of Health Policy and Management
, vol.12, no.1, 2023 (SCI-Expanded, SSCI, Scopus)
6. Comparative Perspective on Financial System in the EU, Country Report on Turkey
Econpapers
, 2012 (Non Peer-Reviewed Journal)
8. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey
METU Studies in Development
, vol.34, no.2, pp.337-385, 2007 (Peer-Reviewed Journal)
9. Refah Devleti ve Sosyal Politikalar
Toplum ve Hekim
, vol.20, no.1, pp.20-27, 2005 (Peer-Reviewed Journal)
10. Gelişmekte olan ülkeler ve Türkiye de İlaç Ürünlerine Yönelik Fikri Mülkiyet Rejimi Değişikliklerinin Siyasal İktisadı
Toplum ve Hekim
, vol.19, no.5, pp.383-393, 2004 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences
8
1. “Biopharmaceutical Financialization and Public Funding of MCMs in Canada during COVID-19 Pandemic”
Society for Social Studies of Science 2022 Annual Conference, 08 December 2022, (Summary Text)
2. “Regulatory Collaboration during COVID-19: Implications for the Future of Health Product Regulation”
Fit for Purpose Regulation Policy Workshop, Dublin, Ireland, 06 November 2022, (Summary Text)
3. “Competitive Interdependence: Political Economy of Drug Regulation during the Pandemic”
Canadian Political Science Association Annual Conference, 2022, 02 June 2022, (Summary Text)
4. Financialisation and Private Equity Fund Investments in the Turkish Healthcare System
7th Annual Conference of the International Initiative for the Promotion of Political Economy, Lizbon, Portugal, 7 - 09 September 2016, (Summary Text)
5. Neoliberalizm Fikri Mülkiyet Hakları ve2000 liyıllarda Türk İlaç Sanayii
13. Sosyal Bilimler Kongresi, Ankara, Turkey, 4 - 06 December 2013, (Full Text)
6. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey
British Political Studies Association 54th Annual Conference, LINCOLN, England, 5 - 08 April 2004, (Full Text)
7. Globalisation and Policy Change
Policy and Politics International Conference, Policy and Politics in a Globalised World, Bristol, England, 24 - 26 July 2003, (Full Text)
8. Could Corporatist Associations become Effective Channels of Interest Representation The Case of Turkish Union of Chamber of Pharmacists
Middle East Studies Association of North America 35th Annual Meeting, San-Francisco, Costa Rica, 17 - 21 November 2001, (Full Text)
Books
8
1. Restricted but significant:Financialisation of Households and Retail Banking Activities in Turkey
in: The Political Economy of Financial Transformation in Turkey, G,Yalman,T. Marois,A.R.Gungen, Editor, Routledge, London/New York , London, pp.269-290, 2018
2. Politics, Reforms, and Regulation of Pharma Prices and Expenditures in Turkey over the 2000s.
in: Pharmaceutical Prices in the 21st Century, Z.-U.-D. Babar, Editor, Springer, London/Berlin , Heidelberg, pp.267-295, 2015
3. İlaç Sanayiinde Fikri Mülkiyet Hakları Rejimi ile İlgili Mücadeleler ve Devletin Uluslararasılaşması
in: Türkiye de Sağlık Siyaset ve Piyasa, Gülbiye Yenimahalleli Yaşar, Asuman Göksel, Ömür Birler, Editor, Nota Bene, Ankara, pp.125-172, 2015
4. Neoliberalism, Intellectual Property Rights and the Turkish Pharmaceutical Industry in the 2000s.
in: The New Political Economy of Pharmaceuticals Production Innovation and TRIPS in the Global South, Hans Löfgren and Owain David Williams, Editor, Palgrave Macmillan, London, pp.221-245, 2013
8. Siyasal İstikrarın Parlementer Kökenleri:İngiltere Üzerine bir Derleme
in: Başkanlık Sistemi ve Türkiye Ülkeler Deneyimler ve Karşılaştırmalı Analiz, İhsan Kamalak, Editor, SODEV Yayinlari, Kalkedon, İstanbul, pp.21-54, 2007
